DionyMed Brands Inc. Expands its Cannabis Brand Portfolio with Défoncé Chocolatier

DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE:DYME; OTCQB:HMDEF), a multi-state cannabis brands, distribution and direct-to-consumer delivery platform, announced today an exclusive licensing and distribution agreement with Défoncé Chocolatier (“Défoncé”).

TORONTO--(BUSINESS WIRE)-- DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE:DYME; OTCQB:HMDEF), a multi-state cannabis brands, distribution and direct-to-consumer delivery platform, announced today an exclusive licensing and distribution agreement with Défoncé Chocolatier (“Défoncé”).

Created and distributed exclusively in California, fine chocolate maker Défoncé is expanding its popular line of premium cannabis-infused chocolate products. In addition to the brand’s acclaimed selection of full-size chocolate bars, new single-serving squares and low-dose bites are now available. All new offerings are gluten free (gf), with vegan (v) options available as well.

“The addition of Défoncé Chocolatier emphasizes our commitment to building a cannabis portfolio of products that are made from the safest, highest-quality ingredients for medical and recreational consumers in California,” said Edward Fields, CEO of DionyMed Brands. “We believe the edibles category is an important path for the canna-curious to explore all the benefits and enjoyment that cannabis offers. Défoncé Chocolatier’s team of veteran artisans, using sun-grown, single-origin cannabis, is delivering on that with California’s best infused chocolate.”

To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves cannabis consumers through retail dispensary distribution and direct-to-consumer fulfillment with its growing portfolio of award-winning brands. Learn more at dionymed.com and follow @DYME_Inc on Twitter and LinkedIn.

About Défoncé

Défoncé is a fine chocolate maker built on high-quality ingredients and a higher quality high. The company sources the finest Belgian chocolate and premium California cannabis extract, marrying the two through its unique, multi-step Clean Infusion Process™ for a confection that is as consistent as it is delicious. The quality and delectable taste of Défoncé’s chocolate can hold its own with the best in the world, all while delivering a clean and safe high, designed for everyone to enjoy. From conception to creation to packaging, it’s all done in the company’s custom, state-of the-art confectionary facility in Oakland, California. At 40,000 square feet, it’s the largest cannabis-infused edibles manufacturing facility in the world. Défoncé products are distributed through DYME Distribution, and available through more than 100 licensed dispensaries and delivery services across California. For more information visit www.defonce.com.

Forward-Looking Information and Statements

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements, including but not limited to the risk factors set out in the Listing Statement of the Company available on the Company’s profile on SEDAR at www.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Contacts

Edward Fields, CEO
edward.fields@dyme.com
669-232-5270

Peter Kampian, CFO
pkampian@dionymed.com
647-948-8387

Investor:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media:
Kate Tumino / Brittany Tibaldi
KCSA Strategic Communications
212-896-1252 / 347-487-6794
ktumino@kcsa.com / btibaldi@kcsa.com

Source: DionyMed Brands Inc.